187 related articles for article (PubMed ID: 33417997)
1. Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.
Krieger NS; Asplin J; Granja I; Chen L; Spataru D; Wu TT; Grynpas M; Bushinsky DA
Kidney Int; 2021 May; 99(5):1118-1126. PubMed ID: 33417997
[TBL] [Abstract][Full Text] [Related]
2. Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.
Krieger NS; Asplin JR; Granja I; Ramos FM; Flotteron C; Chen L; Wu TT; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2019 Jul; 30(7):1163-1173. PubMed ID: 31101664
[TBL] [Abstract][Full Text] [Related]
3. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
4. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
5. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
[TBL] [Abstract][Full Text] [Related]
6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
7. Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Willett T; Asplin JR; Culbertson C; Che SP; Grynpas M
J Bone Miner Res; 2011 Aug; 26(8):1904-12. PubMed ID: 21351146
[TBL] [Abstract][Full Text] [Related]
8. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of hypercalciuria to thiazide in Dent's disease.
Raja KA; Schurman S; D'mello RG; Blowey D; Goodyer P; Van Why S; Ploutz-Snyder RJ; Asplin J; Scheinman SJ
J Am Soc Nephrol; 2002 Dec; 13(12):2938-44. PubMed ID: 12444212
[TBL] [Abstract][Full Text] [Related]
10. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
[TBL] [Abstract][Full Text] [Related]
11. Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study.
Solak V; Gökce Mİ; Yaman Ö
Int Urol Nephrol; 2021 Sep; 53(9):1791-1796. PubMed ID: 33904027
[TBL] [Abstract][Full Text] [Related]
12. Magnesium decreases urine supersaturation but not calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Li Q; Krieger NS; Yang L; Asplin J; Bushinsky DA
Nephron; 2024 Jan; ():. PubMed ID: 38262368
[TBL] [Abstract][Full Text] [Related]
13. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
14. Genetic hypercalciuric stone-forming rats.
Bushinsky DA; Frick KK; Nehrke K
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):403-18. PubMed ID: 16775455
[TBL] [Abstract][Full Text] [Related]
15. The relation between bone and stone formation.
Krieger NS; Bushinsky DA
Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
[TBL] [Abstract][Full Text] [Related]
16. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Laplante K; Asplin JR
Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
[TBL] [Abstract][Full Text] [Related]
17. Low Sodium Diet Decreases Stone Formation in Genetic Hypercalciuric Stone-Forming Rats.
Krieger NS; Grynpas M; VandenEynde A; Asplin JR; Frick KK; Kim MH; Ramos FM; Granja I; Bushinsky DA
Nephron; 2019; 142(2):147-158. PubMed ID: 30726853
[TBL] [Abstract][Full Text] [Related]
18. Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Michalenka AC; Strutz KL; Donahue S; Asplin JR
Kidney Int; 2008 Feb; 73(4):423-9. PubMed ID: 18046318
[TBL] [Abstract][Full Text] [Related]
19. Re: Chlorthalidone is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.
Assimos DG
J Urol; 2020 Jan; 203(1):26. PubMed ID: 31618163
[No Abstract] [Full Text] [Related]
20. A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria.
Okonkwo OW; Batwara R; Granja I; Asplin JR; Goldfarb DS
PLoS One; 2013; 8(4):e60380. PubMed ID: 23593205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
